Dr. Marion Rudolph, Senior Biomarker Expert, Development, Bayer AG, GBM Strategy, Berlin, Germany
"For an early research project, PATH supplied us with approximately 700 tissue specimens and clinical data. The sample quality and the collaboration have been excellent so far. PATH was able to meet our special request for additional material and data in a timely fashion. PATH has shown a high engagement in order to obtain follow up data which were very important for our project. This way we were able to collect follow up data for 98% of the requested cases. In addition, PATH has always been open for discussion and also supported the project on a scientific level."
Prof. Dr. Peter Lichter, Head of the Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
“Together with my colleagues and junior researchers, I take advantage of the PATH Biobank‘s impressive collection of tumor tissue, normal tissue and serum. The samples are of high quality and the process of obtaining the material is professionally handled. Special requests are accepted and usually realized. I find it remarkable that former patients are running such an incredibly useful biobank.”
Prof. Dr. Dr. Axel Ullrich, Director of the Department of Molecular Biology, Max-Planck Institute for Biochemistry, Martinsried, Germany
"There is a shortage of fresh frozen tumor samples for breast cancer research. That is one reason why I encouraged the founding of PATH Biobank. I am glad that breast cancer survivors have taken the initiative and - through PATH - are making a major contribution to advancing cancer research. The PATH Biobank is well-stocked, professionally managed and, as a patient-run tumor bank, independent from individual interests."